Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Menu

    Brilaroxazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 117,418Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Reviva to Present Poster on RECOVER Trial at 2025 ASCP Meeting
    Reviva to Present Poster on RECOVER Trial at 2025 ASCP Meeting

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067346/0/en/Reviva-to-Present-Late-Breaking-Poster-on-the-RECOVER-Long-term-Open-Label-Extension-Trial-for-Brilaroxazine-in-Schizophrenia-at-the-2025-ASCP-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Reviva to Present Brilaroxazine Data at 2025 SIRS Congress
    Reviva to Present Brilaroxazine Data at 2025 SIRS Congress

    30 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/30/3051893/0/en/Reviva-to-Present-Brilaroxazine-Topline-Data-for-Long-Term-OLE-Portion-of-RECOVER-Study-in-Schizophrenia-at-2025-SIRS-Congress.html

    GLOBENEWSWIRE
    30 Mar 2025
    Share Share
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024
    Reviva to Present Brilaroxazine Speech Data at CNS Summit 2024

    06 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/06/2975650/0/en/Reviva-to-Present-Positive-Speech-Latency-Data-for-Brilaroxazine-in-Schizophrenia-From-the-Phase-3-RECOVER-Trial-at-the-CNS-Summit-2024.html

    GLOBENEWSWIRE
    06 Nov 2024
    Share Share
    Reviva Pharmaceuticals To Participate In Lytham Conference
    Reviva Pharmaceuticals To Participate In Lytham Conference

    26 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/26/2953812/0/en/Reviva-Pharmaceuticals-to-Participate-in-the-Lytham-Partners-Fall-2024-Investor-Conference.html

    GLOBENEWSWIRE
    26 Sep 2024
    Share Share
    Reviva Announces New Vocal Biomarker Data
    Reviva Announces New Vocal Biomarker Data

    09 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/09/2942764/0/en/Reviva-Announces-New-Vocal-Biomarker-Data-from-Phase-3-RECOVER-Trial-of-Brilaroxazine-in-Schizophrenia.html

    GLOBENEWSWIRE
    09 Sep 2024
    Share Share
    Reviva To Join H.C. Wainwright Investment Conference
    Reviva To Join H.C. Wainwright Investment Conference

    04 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/04/2940452/0/en/Reviva-to-Participate-in-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html

    GLOBENEWSWIRE
    04 Sep 2024
    Share Share